Sue Cheeseman

579 total citations
23 papers, 178 citations indexed

About

Sue Cheeseman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sue Cheeseman has authored 23 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Sue Cheeseman's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Sue Cheeseman is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Sue Cheeseman collaborates with scholars based in United Kingdom, United States and Belgium. Sue Cheeseman's co-authors include Malcolm Ranson, J. Margison, Shane White, Anthony Howell, Matthew D. Thompson, Geoff Hall, H Anderson, G. Ross, Bernadette M. Carrington and Will Sopwith and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sue Cheeseman

22 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Cheeseman United Kingdom 7 94 86 42 36 24 23 178
Luigi Della Gravara Italy 8 117 1.2× 102 1.2× 54 1.3× 8 0.2× 15 0.6× 21 192
Jorge Hidalgo Argentina 4 84 0.9× 99 1.2× 37 0.9× 16 0.4× 15 0.6× 5 174
Jayhyun Seo United States 5 152 1.6× 63 0.7× 24 0.6× 5 0.1× 14 0.6× 7 214
Marzia Falanga Italy 8 103 1.1× 84 1.0× 67 1.6× 6 0.2× 6 0.3× 12 195
Roberto Díaz Beveridge Spain 6 88 0.9× 36 0.4× 13 0.3× 10 0.3× 14 0.6× 13 128
Koichiro Nozaki Japan 9 133 1.4× 72 0.8× 54 1.3× 3 0.1× 10 0.4× 16 237
Danielle D. Jandial United States 5 97 1.0× 15 0.2× 77 1.8× 9 0.3× 22 0.9× 7 217
Gaku Yamamichi Japan 9 45 0.5× 63 0.7× 39 0.9× 3 0.1× 16 0.7× 31 148
Shen Lao China 6 89 0.9× 39 0.5× 50 1.2× 5 0.1× 3 0.1× 11 172

Countries citing papers authored by Sue Cheeseman

Since Specialization
Citations

This map shows the geographic impact of Sue Cheeseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Cheeseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Cheeseman more than expected).

Fields of papers citing papers by Sue Cheeseman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Cheeseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Cheeseman. The network helps show where Sue Cheeseman may publish in the future.

Co-authorship network of co-authors of Sue Cheeseman

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Cheeseman. A scholar is included among the top collaborators of Sue Cheeseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Cheeseman. Sue Cheeseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheeseman, Sue, et al.. (2025). Establishing standards: harmonising coding principles for a minimal cancer dataset in the OMOP Common Data Model. PubMed. 9. 100179–100179. 1 indexed citations
2.
Guérin‐Charbonnel, Catherine, François C. Bocquet, Sue Cheeseman, et al.. (2024). Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer. ESMO Open. 9(9). 103694–103694. 5 indexed citations
3.
Cheeseman, Sue, et al.. (2024). Evaluation of machine learning methods for the retrospective detection of ovarian cancer recurrences from chemotherapy data. SHILAP Revista de lepidopterología. 4. 100038–100038. 1 indexed citations
4.
Calleja, Alan, M. Daumont, John R. Penrod, et al.. (2024). Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis. Future Oncology. 20(23). 1633–1643. 1 indexed citations
5.
Cottu, Paul, Sue Cheeseman, Peter Hall, et al.. (2024). Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records. Breast Cancer Research and Treatment. 209(2). 419–430. 1 indexed citations
6.
7.
8.
9.
10.
Twelves, Chris, Sue Cheeseman, Will Sopwith, et al.. (2020). Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre. BMC Cancer. 20(1). 53–53. 11 indexed citations
11.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2019). P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative. Journal of Thoracic Oncology. 14(10). S812–S812. 1 indexed citations
12.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2019). Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative. Annals of Oncology. 30. ii14–ii15. 1 indexed citations
13.
14.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2018). P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database. Journal of Thoracic Oncology. 13(10). S700–S700. 4 indexed citations
15.
Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2018). P82 Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: retrospective analysis of a UK trust database. A145.2–A146. 2 indexed citations
16.
Hall, Peter, Simon Lord, Michelle Collinson, et al.. (2017). A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). British Journal of Cancer. 116(4). 472–478. 27 indexed citations
17.
Hall, Peter, Simon Lord, Michelle Collinson, et al.. (2012). Three, two, or one drug chemotherapy for frail or elderly patients with advanced gastroesophageal cancer (321GO): A feasibility study.. Journal of Clinical Oncology. 30(4_suppl). 97–97. 1 indexed citations
18.
Ranson, Malcolm, Sue Cheeseman, Shane White, & J. Margison. (2001). Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer. Critical Reviews in Oncology/Hematology. 37(2). 115–120. 37 indexed citations
19.
White, Stuart C., Sue Cheeseman, Nick Thatcher, et al.. (2000). Phase II study of oral topotecan in advanced non-small cell lung cancer.. PubMed. 6(3). 868–73. 28 indexed citations
20.
Ranson, Malcolm, Anthony Howell, Sue Cheeseman, & J. Margison. (1996). Liposomal drug delivery. Cancer Treatment Reviews. 22(5). 365–379. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Della Gravara Breakdown of academic impact, for papers by Jorge Hidalgo Breakdown of academic impact, for papers by Jayhyun Seo Breakdown of academic impact, for papers by Marzia Falanga Breakdown of academic impact, for papers by Roberto Díaz Beveridge Breakdown of academic impact, for papers by Koichiro Nozaki Breakdown of academic impact, for papers by Danielle D. Jandial Breakdown of academic impact, for papers by Gaku Yamamichi Breakdown of academic impact, for papers by Shen Lao
Rankless by CCL
2026